OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma
出版年份 2012 全文链接
标题
OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma
作者
关键词
Squamous cell carcinomas, Apoptosis, Cell cycle and cell division, Prognosis, Gene expression, Cell staining, MTT assay, Vector construction
出版物
PLoS One
Volume 7, Issue 11, Pages e49693
出版商
Public Library of Science (PLoS)
发表日期
2012-11-22
DOI
10.1371/journal.pone.0049693
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer Stem Cells and Novel Targets for Antitumor Strategies
- (2012) Gerald J. Prud’homme CURRENT PHARMACEUTICAL DESIGN
- Overexpression of survivin and cyclin D1 in CHO cells confers apoptosis resistance and enhances growth in serum-free suspension culture
- (2011) Xinghui Zhao et al. BIOTECHNOLOGY LETTERS
- Overcoming Erlotinib Resistance in EGFR Mutation-Positive Non-Small Cell Lung Cancer Cells by Targeting Survivin
- (2011) K. Okamoto et al. MOLECULAR CANCER THERAPEUTICS
- Survivin Silencing as a Promising Strategy To Enhance the Sensitivity of Cancer Cells to Chemotherapeutic Agents
- (2011) S. Trabulo et al. MOLECULAR PHARMACEUTICS
- Over-expression of Oct4 in human esophageal squamous cell carcinoma
- (2011) Xi Zhou et al. MOLECULES AND CELLS
- Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44
- (2011) Jiang-Sha Zhao et al. PLoS One
- Survivin as a global target of intrinsic tumor suppression networks
- (2010) Minakshi Guha et al. CELL CYCLE
- Tumor Survivin Is Downregulated by the Antisense Oligonucleotide LY2181308: A Proof-of-Concept, First-in-Human Dose Study
- (2010) D. C. Talbot et al. CLINICAL CANCER RESEARCH
- Cancer stem cells: the theory and perspectives in cancer therapy
- (2010) Justyna Gil et al. JOURNAL OF APPLIED GENETICS
- Expression of Oct4 in HCC and modulation to wnt/β-catenin and TGF-β signal pathways
- (2010) FangJun Yuan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Preoperative survivin mRNA detection in peripheral blood is an independent predictor of outcome in esophageal carcinoma
- (2010) Andreas-Claudius Hoffmann et al. PHARMACOGENOMICS
- Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance
- (2009) Mei Cao et al. CLINICAL & EXPERIMENTAL METASTASIS
- Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non–Small-Cell Lung Cancer
- (2009) Giuseppe Giaccone et al. JOURNAL OF CLINICAL ONCOLOGY
- Oct4, a novel marker for human gastric cancer
- (2009) Zhong Chen et al. JOURNAL OF SURGICAL ONCOLOGY
- Regulation of Stem Cell Pluripotency and Differentiation Involves a Mutual Regulatory Circuit of the Nanog, OCT4, and SOX2 Pluripotency Transcription Factors With Polycomb Repressive Complexes and Stem Cell microRNAs
- (2009) Vasundhra Kashyap et al. STEM CELLS AND DEVELOPMENT
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell Carcinoma
- (2008) S.-H. Chiou et al. CLINICAL CANCER RESEARCH
- The influence of survivin shRNA on the cell cycle and the invasion of SW480 cells of colorectal carcinoma
- (2008) Liu Zhonghong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells
- (2008) Yu-Chih Chen et al. PLoS One
- Oct-4 Is Critical for Survival/Antiapoptosis of Murine Embryonic Stem Cells Subjected to Stress: Effects Associated with Stat3/Survivin
- (2007) Ying Guo et al. STEM CELLS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started